Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sangamo Therapeutics Inc

0.9364
+0.06157.03%
Volume:2.34M
Turnover:2.13M
Market Cap:195.38M
PE:-1.34
High:0.9550
Open:0.8562
Low:0.8150
Close:0.8749
Loading ...

Analysts Just Made A Massive Upgrade To Their Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Forecasts

Simply Wall St.
·
20 Nov 2024

BUZZ-Sangamo Therapeutics rises after FDA clears application to start trial for pain treatment

Reuters
·
20 Nov 2024

Sangamo Therapeutics Shares up 12.2% Premarket After FDA Clears Application to Start Trial for Pain Treatment

THOMSON REUTERS
·
20 Nov 2024

BRIEF-Sangamo Therapeutics Announces U.S. FDA Clearance Of IND Application For ST-503

Reuters
·
20 Nov 2024

Sangamo Therapeutics Gets FDA Clearance for Investigational NDA for Pain Treatment

Dow Jones
·
20 Nov 2024

Sangamo gets FDA clearance of IND application for ST-503 in iSFN

TIPRANKS
·
20 Nov 2024

Sangamo up 11% at $2.17 on FDA clearing IND for ST-503

TIPRANKS
·
20 Nov 2024

Sangamo Therapeutics Announces U.S. FDA Clearance of Ind Application for St-503 for the Treatment of Idiopathic Small Fiber Neuropathy, a Type of Chronic Neuropathic Pain

THOMSON REUTERS
·
20 Nov 2024

Sangamo Therapeutics Inc - to Initiate Phase 1/2 Study for St-503 in Mid-2025

THOMSON REUTERS
·
20 Nov 2024

Sangamo Therapeutics Announces U.S. FDA Clearance of IND Application for ST-503 for the Treatment of Idiopathic Small Fiber Neuropathy, a Type of Chronic Neuropathic Pain

Business Wire
·
20 Nov 2024

Sangamo Therapeutics Third Quarter 2024 Earnings: Beats Expectations

Simply Wall St.
·
15 Nov 2024

Sangamo Therapeutics Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

Dow Jones
·
15 Nov 2024

Sangamo Therapeutics Inc. : Barclays Raises Target Price to $9 From $3

THOMSON REUTERS
·
14 Nov 2024

Wells Fargo Gives a Hold Rating to Sangamo Biosciences (SGMO)

TIPRANKS
·
14 Nov 2024

Sangamo Biosciences: Mine Safety Regulations Pose No Risk to Operations

TIPRANKS
·
14 Nov 2024

Q3 2024 Sangamo Therapeutics Inc Earnings Call

Thomson Reuters StreetEvents
·
13 Nov 2024